KX01 Ointment Phase 1 Study in Patients With Plaque Type Psoriasis
Status:
Completed
Trial end date:
2021-03-10
Target enrollment:
Participant gender:
Summary
This is a Phase I dose escalation study to assess the safety, tolerability and activity of
three different strengths of topical KX01 in the treatment of patients with plaque-type
psoriasis.